Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Laboratory in-vitro experimental use only
A single molecular entity simultaneously activates both the GLP-1 receptor and the amylin receptor (calcitonin receptor complex), combining two complementary satiety and metabolic pathways: GLP-1 receptor activation : Glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying, and central appetite reduction through hypothalamic signaling Amylin receptor activation : Additional satiety signaling through the area postrema, complementary gastric emptying delay, and glucagon suppression through a distinct mechanism The unimolecular design means both receptor activations occur at a fixed ratio determined by the molecular structure
sale restricted to research-only contexts
A COA indicating 99% purity by HPLC means that 99% or more of the peptide content is the correct GHK-Cu sequence, with minimal contaminants
US$ 21.02
US$ 22.09
US$ 21.67
US$ 25.70
US$ 27.75
US$ 22.73
US$ 23.58
US$ 29.74
